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Abstract
Primary malignant melanoma rarely occurs in the external auditory canal. 
In the few reported cases, treatment with lateral temporal bone resec-
tion, superficial parotidectomy, and neck dissection were suggested. We 
describe a 52-year-old man with this disease, managed by sentinel node 
biopsy with lymphoscintigraphy guidance, lateral temporal bone resec-
tion, and postoperative radiotherapy. The patient refused superficial 
parotidectomy and neck dissection. Although there was no locoregional 
recurrence on follow-up, pulmonary metastasis was diagnosed in the 
third year after treatment. The incidence, symptoms, treatment, and prog-
nosis of external auditory canal malignant melanoma are also discussed 
in this article. [Tzu Chi Med J 2009;21(3):244–247]
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1. Introduction
The cause of malignant melanoma of the skin is 
mainly attributed to overexposure to the ultraviolet 
component of sunlight. Genetic factors, skin freckles, 
fair skin, light hair, age, and immunosuppression 
are other predisposing factors [1,2], with Caucasians 
being more susceptible. Malignant melanoma 
arising from the external auditory canal (EAC) is a 
rare disease, with few reports in the medical litera-
ture [1–4]. In this article, we report a case in an Asian 
patient.
2. Case report
A previously healthy 52-year-old man presented with 
a 4-month history of a blockage sensation in his right 
ear. Inspection showed a protruding dark fleshy mass 
filling the entire right EAC, arising from the posterior 
aspect (Fig. 1). Neurologic and head and neck exami-
nation showed no other specific findings. Axial and 
coronal views of a preoperative computed tomogra-
phy scan of the temporal bone showed a soft-tissue 
mass (about 1.3 ˜  0.8 ˜  0.6 cm) filling the right EAC 
(Fig. 2). Biopsy specimens obtained from this mass 
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revealed sheets of oval- to spindle-shaped cells with 
melanin pigments of great variation in size and shape 
(Fig. 3). These cells stained positively with the HMB-45 
and S-100 (Fig. 3) stains, but negatively with the cy-
tokeratin AE1/AE3 stain. Melanin pigments—as con-
firmed by a Fontana-Masson stain—were present in 
both the oval- to spindle-shaped cells and the macro-
phages in the stroma. Malignant melanoma of the EAC 
was diagnosed.
Whole body positron emission tomography showed 
no evidence of distant metastasis. The patient was 
informed of the necessity of a lateral temporal bone 
resection, superficial parotidectomy, and ipsilateral 
neck dissection. However, the patient refused the ex-
tended superficial parotidectomy and neck dissec-
tion. Lymphoscintigraphy (Fig. 3) with sentinel node 
biopsy showed no nodal metastasis. The patient sub-
sequently underwent a lateral temporal bone resec-
tion and postoperative radiotherapy. The tumor was 
resected with a 2 cm safety margin and the pathology 
report revealed that the margins were all disease-
free. The patient was regularly followed in our 
outpatient department for 3 years. Unfortunately, 
metastasis developed in the lungs in the third year, 
although there was no local recurrence (Fig. 1).
3. Discussion
Malignant melanoma of the ear is estimated to occur 
in 1–4% of all skin melanomas and about 7–20% of 
melanomas of the head and neck region [1,3,4]. The 
mean age at diagnosis is reported to be around 50 
years; all age groups are affected except for younger 
populations. The most frequently involved areas of 
auricular melanoma are the helix and ear lobule. 
Malignant melanoma confined to the EAC is rarely 
reported in the literature [1,2,5,6].
The presenting symptoms of malignant melanoma 
of the EAC are hearing loss, sensation of a blocked ear 
or foreign body, and discharge from the ears [1,2,5,6]. 
These nonspecific symptoms are often ignored by 
patients until near total blockage of the EAC occurs. 
There should be a high index of suspicion of a pos-
sible malignant melanoma when a pigmented lesion 
changes color, enlarges rapidly, or ulcerates with poor 
healing. Excisional biopsy of these lesions is advised.
The optimal management of malignant melano-
mas of the ear is total surgical excision with at least 
a 1–2 cm safety margin in consideration of possible 
satellite lesions [3]. Sometimes, it is more difficult to 
excise malignant melanomas inside the EAC because 
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Fig. 1 — (A–D) Macroscopic views of a protruding dark fleshy mass filling the entire right external auditory canal arising 
from dark skin at the posterior aspect of the external auditory canal wall. (E) Macroscopic view of the ear 3 years post-
operatively. Physical examination showed a dry cavity without local recurrence.
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Fig. 2 — (A, B) Axial and coronal views of preoperative computed tomography. White arrowheads show a soft-tissue mass 
measuring about 1.3 ´  0.8 ´  0.6 cm filling the right external auditory canal. (C, D) Right lateral view and anterior view on 
lymphoscintigraphy (white arrowheads) show the sentinel lymph node below the main tumor. Sentinel lymph node 
mapping and excisional biopsy were completed before the operation on the main tumor.
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Fig. 3 — (A) Nests of polyhedral and spindle-shaped tumor cells with melanin pigments in the cytoplasm and polymorphism 
of the nuclei (hematoxylin & eosin, 100´). (B) The tumor cells stained positively with the S-100 protein immunohisto-
chemical stain (200´).
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of the limited space between the lesion, and the 
neighboring delicate and vital structures of the mid-
dle/inner ears. Wide local excision of a malignant 
melanoma in the EAC often leads to recurrence of 
disease and mortality within 2 years. Removal of the 
tumor with a margin of surrounding bone is the min-
imal requirement in treating the primary focus [1].
For the clinically negative neck, the treatment is 
rather controversial. Routinely, a superficial parotid-
ectomy with a neck dissection has been suggested 
[1–3,5,6]. However, several prospective trials of pa-
tients with cutaneous malignant melanomas could 
not find a definitive benefit of elective lymph node 
dissection on patient survival [7,8]. Therefore, the 
value of elective neck dissection for the patient with 
melanoma of the ear is still undetermined.
Morton et al first reported a sentinel lymph node 
biopsy to drain a lymph node in a malignant melanoma 
of the head and neck [9]. Later studies showed that 
lymphoscintigraphy with sentinel node biopsy helped 
in decision making regarding neck dissection and 
yielded a high success rate and low morbidity in pa-
tients with a clinically negative neck [7]. However, 
many large retrospective studies failed to show a 
positive relationship between positive results from 
a sentinel node biopsy and survival. Nevertheless, it 
remains the most useful staging and prognostic indi-
cator at the present time and the results of sentinel 
node biopsy do help high risk patients in the deter-
mination of possible adjuvant therapies [7,8].
When there is neck metastasis, functional neck 
dissection and high doses of interferon alpha 2b are 
suggested. Other possible adjuvant therapies such 
as immunomodulation therapy, vaccination, radia-
tion therapy and chemotherapy have been discussed, 
although no definitive survival benefits have been 
reported [10].
Tumor thickness is the most important prognostic 
factor of malignant melanoma of the skin, but a nod-
ular pattern, ulceration, and regional or distant me-
tastases are associated with a poor prognosis. Other 
poor prognostic factors for malignant melanoma in 
the EAC include delayed diagnosis because of its deep 
location, a greater tendency for metastasis due to the 
thin epithelium, a short distance between the tumor 
and the dermal lymphatics, and a previously failed 
surgical excision [1].
In summary, malignant melanomas of the EAC are 
extremely rare, especially in Asians, and the utility of 
sentinel node biopsy has not been mentioned in pre-
vious case reports [1,2,5,6]. We reported a case that 
was staged and treated using lymphoscintigraphy 
with sentinel node biopsy, lateral temporal bone re-
section, and postoperative radiotherapy. Both whole 
body positron emission tomography scanning and 
sentinel node biopsy before treatment showed no re-
gional or distant metastasis, and the patient was 
under complete locoregional control after treatment. 
However, pulmonary metastasis eventually devel-
oped after 3 years. This highlights EAC melanoma 
as a grave disease with a systemic predisposition 
and poor prognosis; long-term follow-up is necessary 
despite good locoregional control.
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